Literature DB >> 14556945

Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene.

Tetsuro Murakami1, Hristelina Ilieva, Mito Shiote, Tetsuya Nagata, Isao Nagano, Mikio Shoji, Koji Abe.   

Abstract

Localization and hypoxic induction of vascular endothelial growth factor (VEGF) was examined in the spinal cord of transgenic mice carrying a mutation in the superoxide dismutase 1 gene. Immunohistochemical and immunofluorescent study demonstrated that VEGF is mainly expressed in motor neurons before and after hypoxia. Baseline expression of VEGF was higher in transgenic (Tg) mice than in wild-type (Wt) littermates. However, VEGF was hardly induced after hypoxia in Tg mice, whereas Wt mice showed an approximate nine-fold increase. Impaired VEGF induction was evident in Tg mice at 12 weeks of age, when they were still presymptomatic. In contrast, baseline and hypoxic expression of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor did not differ between Tg and Wt mice. Thus, the present study demonstrates that hypoxic induction of VEGF in Tg mice is selectively impaired from a very early stage, suggesting profound involvement in the pathogenesis of motor neuron degeneration in this animal model of amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556945     DOI: 10.1016/s0006-8993(03)03374-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

Authors:  Kazunori Miyazaki; Kazuto Masamoto; Nobutoshi Morimoto; Tomoko Kurata; Takahumi Mimoto; Takayuki Obata; Iwao Kanno; Koji Abe
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

Review 2.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

Review 3.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

4.  Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice.

Authors:  Gavriel David; Khanh Nguyen; Ellen F Barrett
Journal:  Exp Neurol       Date:  2007-01-04       Impact factor: 5.330

Review 5.  HIF-1 and ventilatory acclimatization to chronic hypoxia.

Authors:  Frank L Powell; Zhenxing Fu
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

6.  Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Yasuyuki Ohta; Makiko Nagai; Kazunori Miyazaki; Nobuhito Tanaka; Hiromi Kawai; Takafumi Mimoto; Nobutoshi Morimoto; Tomoko Kurata; Yoshio Ikeda; Tohru Matsuura; Koji Abe
Journal:  Cell Med       Date:  2011-10-01

7.  Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.

Authors:  Ana G Barbeito; Laura Martinez-Palma; Marcelo R Vargas; Mariana Pehar; Nelly Mañay; Joseph S Beckman; Luis Barbeito; Patricia Cassina
Journal:  Neurobiol Dis       Date:  2009-11-13       Impact factor: 5.996

8.  Nocturnal hypoxia in ALS is related to cognitive dysfunction and can occur as clusters of desaturations.

Authors:  Su-Yeon Park; Sung-Min Kim; Jung-Joon Sung; Kyung-Min Lee; Kyung-Seok Park; Sang-Yun Kim; Hyun-woo Nam; Kwang-Woo Lee
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 9.  Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis.

Authors:  Ana Catarina Pronto-Laborinho; Susana Pinto; Mamede de Carvalho
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

10.  Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice.

Authors:  Sung-Min Kim; Heejaung Kim; Jeong-Seon Lee; Kyung Seok Park; Gye Sun Jeon; Jeeheun Shon; Suk-Won Ahn; Seung Hyun Kim; Kyung Min Lee; Jung-Joon Sung; Kwang-Woo Lee
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.